查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1654277

肥胖治療市場規模、佔有率、趨勢分析報告：按藥物類別、給藥途徑、分銷管道、地區、細分預測，2025-2030 年

Obesity Treatment Market Size, Share & Trends Analysis Report By Drug Class, By Route Of Administration, By Distribution Channel, By Region, And Segment Forecasts, 2025 - 2030
出版日期: | 出版商: Grand View Research | 英文 153 Pages | 商品交期: 2-10個工作天內

價格

肥胖治療市場的成長與趨勢：

預計2030年全球肥胖治療市場規模將達605.3億美元，2025年至2030年複合年成長率為22.31%。

久坐的生活方式、缺乏運動和不健康的飲食習慣日益增加是導致肥胖症高發生率的關鍵因素。根據衛生指標與評估研究所的數據，全球約有 30.0% 的人口肥胖或超重。

此外，市場上體重管理解決方案的出現，以及產業參與者引入的技術進步和政府採取的倡導舉措，正在提高人們對肥胖及其對健康影響的認知。這進一步推動了肥胖治療市場的成長。

體重管理有很多方法，包括飲食、運動、藥物、微創設備和植入以及手術。在常用藥物中，組合藥物佔據了最大的市場佔有率，而能產生飽腹感的飽腹劑是肥胖治療市場中成長最快的部分。

在外科手術中，胃繞道手術是成長最快的領域，而微創內視鏡手術領域則成長最快，該領域涉及植入和設備（例如飽食裝置和胃排放裝置）的外科植入。

私營部門的激烈競爭正在推動私人醫院和診所向提供最先進的肥胖症治療技術邁進和創新。因此，微創手術的需求正在迅速成長。此外，人們對肥胖和相關疾病的認知不斷提高，以及體重管理解決方案的商業化正在推動肥胖治療市場的發展。

肥胖治療市場報告重點

  • 依藥物類別分為GLP-1受體促效劑、脂肪酶抑制劑、食慾抑制劑、其他藥物類別。
  • 根據給藥途徑，肥胖症治療市場分為腸外給藥和口服給藥。
  • 依分銷管道分為醫院藥局、零售藥局、其他。
  • 預計預測期內其他藥局也將大幅成長。
  • 北美肥胖治療市場在全球產業中佔據主導地位，2024 年的收益佔有率為 73.39%。

目錄

第1章調查方法與範圍

第 2 章執行摘要

第 3 章肥胖治療市場變數、趨勢與範圍

  • 母市場展望
  • 補貼市場前景
  • 市場動態
    • 市場促進因素分析
    • 市場限制因素分析
  • 肥胖治療分析工具
    • 波特的分析
    • PESTEL 分析

第 4 章肥胖治療市場：藥物類別估計與趨勢分析

  • 肥胖治療市場：藥物類別細分儀表板
  • 肥胖治療市場：藥物類別變化分析
  • GLP-1 受體促效劑
    • Semaglutide（Wegovy）
    • 利拉魯Liraglutide（Saxenda）
    • Tirzepatide（Zepbound）
  • 脂肪酶抑制劑
  • 食慾抑制劑
  • 其他藥物類別

第 5 章肥胖治療市場：估計給藥途徑與趨勢分析

  • 肥胖治療市場：給藥途徑細分儀表板
  • 肥胖治療市場：給藥途徑變化分析
  • 腸外
  • 口服

第6章 肥胖治療市場：通路評估與趨勢分析

  • 肥胖治療市場：分銷通路細分儀表板
  • 肥胖治療市場：通路變化分析
  • 醫院藥房
  • 零售藥局
  • 其他

第7章肥胖治療市場：區域估計與趨勢分析

  • 肥胖治療市場佔有率
  • 北美洲
    • 美國
    • 加拿大
    • 墨西哥
  • 歐洲
    • 英國
    • 德國
    • 法國
    • 義大利
    • 西班牙
    • 丹麥
    • 挪威
    • 瑞典
  • 亞太地區
    • 中國
    • 日本
    • 印度
    • 韓國
    • 澳洲
    • 泰國
  • 拉丁美洲
    • 巴西
    • 阿根廷
  • 中東和非洲
    • 沙烏地阿拉伯
    • 阿拉伯聯合大公國
    • 科威特
    • 南非

第8章 競爭格局

  • 主要市場參與企業的近期趨勢和影響分析
  • 公司分類
  • 2024 年公司市場佔有率分析
  • 2024 年企業熱圖分析
  • 公司簡介
    • Novo Nordisk A/S.
    • GSK plc.
    • VIVUS LLC
    • Currax Pharmaceuticals
    • Boehringer Ingelheim International GmbH
    • Rhythm Pharmaceuticals, Inc.
    • Gelesis
    • Eli Lilly and Company.
Product Code: GVR-1-68038-095-8

Obesity Treatment Market Growth & Trends:

The global obesity treatment market size is expected to reach USD 60.53 billion in 2030 and is anticipated to grow at a CAGR of 22.31% from 2025 to 2030. The upward trend in sedentary lifestyles, physical inactivity, and unhealthy food habits are the vital factors responsible for the high prevalence of obesity. According to the Institute of Health Metrics and Evaluation, about 30.0% of the global population is either obese or overweight.

Additionally, along with commercial availability of solutions for weight management, technological advancements introduced by the vertical players and supportive initiatives undertaken by the governments, create more awareness with regard to obesity and its impact on health. This is further driving the growth of the obesity treatment market.

There are various approaches for weight management such as diet, exercise, drugs, minimally invasive devices & implants, and surgeries. Amongst the prevalent drugs, the combination drugs hold the largest market share whereas satiety drugs that provide a feeling of fullness appear as the fastest-growing segment in the obesity treatment market.

In surgeries, gastric bypass procedures form the largest growing segment whereas the minimally invasive endoscopic procedure segment that involves surgical placement of implants and devices, such as satiety devices and gastric emptying devices, is the fastest-growing space.

Intense competition in the private sector has driven advancements and innovation toward the development of the latest techniques for obesity treatment that are offered in private hospitals and clinics. As a result, the demand for minimally invasive procedures is swiftly increasing. In addition, increasing awareness of obesity & the associated diseases and the commercial availability of weight management solutions is propelling the obesity treatment market.

Obesity Treatment Market Report Highlights:

  • Based on drug class, the industry has been categorized into GLP-1 receptor agonists, lipase inhibitors, appetite suppressants, and other drug classes
  • Based on the route of administration, the obesity treatment market has been categorized into parenteral and oral
  • Based on distribution channels, the market has been categorized into hospital pharmacies, retail pharmacies, and others.
  • The other pharmacies are expected to grow at a considerable growth of over the forecast period
  • North America obesity treatment market dominated the global industry with a revenue share of 73.39% in 2024

Table of Contents

Chapter 1. Methodology and Scope

  • 1.1. Market Segmentation and Scope
  • 1.2. Market Definitions
  • 1.3. Research Methodology
    • 1.3.1. Information Procurement
    • 1.3.2. Information or Data Analysis
    • 1.3.3. Market Formulation & Data Visualization
    • 1.3.4. Data Validation & Publishing
  • 1.4. Research Scope and Assumptions
    • 1.4.1. List of Data Sources

Chapter 2. Executive Summary

  • 2.1. Market Outlook
  • 2.2. Segment Outlook
  • 2.3. Competitive Insights

Chapter 3. Obesity Treatment Market Variables, Trends, & Scope

  • 3.1. Parent Market Outlook
  • 3.2. Ancillary Market Outlook
  • 3.3. Market Dynamics
    • 3.3.1. Market Drivers Analysis
      • 3.3.1.1. Increasing prevalence of obesity-related conditions
      • 3.3.1.2. Government regulations and guidelines
      • 3.3.1.3. Advancements in treatment options
    • 3.3.2. Market Restraints Analysis
      • 3.3.2.1. Side effects and adverse reactions
      • 3.3.2.2. High cost of anti-obesity drugs
  • 3.4. Obesity Treatment Analysis Tools
    • 3.4.1. Porter's Analysis
      • 3.4.1.1. Bargaining power of the suppliers
      • 3.4.1.2. Bargaining power of the buyers
      • 3.4.1.3. Threats of substitution
      • 3.4.1.4. Threats from new entrants
      • 3.4.1.5. Competitive rivalry
    • 3.4.2. PESTEL Analysis
      • 3.4.2.1. Political landscape
      • 3.4.2.2. Economic and Social landscape
      • 3.4.2.3. Technological landscape
      • 3.4.2.4. Environmental landscape
      • 3.4.2.5. Legal landscape

Chapter 4. Obesity Treatment Market: By Drug Class Estimates & Trend Analysis

  • 4.1. Obesity Treatment Market: Drug Class Segment Dashboard
  • 4.2. Obesity Treatment Market: By Drug Class Movement Analysis, USD Million, 2024 & 2030
  • 4.3. GLP-1 Receptor Agonists
    • 4.3.1. GLP-1 Receptor Agonists Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 4.3.2. Semaglutide (Wegovy)
      • 4.3.2.1. Semaglutide (Wegovy) Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 4.3.3. Liraglutide (Saxenda)
      • 4.3.3.1. Liraglutide (Saxenda) Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 4.3.4. Tirzepatide (Zepbound)
      • 4.3.4.1. Tirzepatide (Zepbound) Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 4.4. Lipase Inhibitors
    • 4.4.1. Lipase Inhibitors Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 4.5. Appetite Suppressants
    • 4.5.1. Appetite Suppressants Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 4.6. Other Drug Class
    • 4.6.1. Other Drug Class Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)

Chapter 5. Obesity Treatment Market: Route of Administration Estimates & Trend Analysis

  • 5.1. Obesity Treatment Market: Route of Administration Segment Dashboard
  • 5.2. Obesity Treatment Market: By Route of Administration Movement Analysis, USD Million, 2024 & 2030
  • 5.3. Parenteral
    • 5.3.1. Parenteral Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 5.4. Oral
    • 5.4.1. Oral Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)

Chapter 6. Obesity Treatment Market: Distribution Channel Estimates & Trend Analysis

  • 6.1. Obesity Treatment Market: Distribution Channel Segment Dashboard
  • 6.2. Obesity Treatment Market: Distribution Channel Movement Analysis, USD Million, 2024 & 2030
  • 6.3. Hospital Pharmacies
    • 6.3.1. Hospital Pharmacies Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 6.4. Retail Pharmacies
    • 6.4.1. Retail Pharmacies Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 6.5. Others
    • 6.5.1. Others Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)

Chapter 7. Obesity Treatment Market: Regional Estimates & Trend Analysis

  • 7.1. Obesity Treatment Market Share, By Region, 2024 & 2030, USD Million
  • 7.2. North America
    • 7.2.1. North America Obesity Treatment Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 7.2.2. U.S.
      • 7.2.2.1. U.S. Obesity Treatment Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 7.2.3. Canada
      • 7.2.3.1. Canada Obesity Treatment Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 7.2.4. Mexico
      • 7.2.4.1. Mexico Obesity Treatment Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 7.3. Europe
    • 7.3.1. Europe Obesity Treatment Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 7.3.2. UK
      • 7.3.2.1. UK Obesity Treatment Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 7.3.3. Germany
      • 7.3.3.1. Germany Obesity Treatment Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 7.3.4. France
      • 7.3.4.1. France Obesity Treatment Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 7.3.5. Italy
      • 7.3.5.1. Italy Obesity Treatment Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 7.3.6. Spain
      • 7.3.6.1. Spain Obesity Treatment Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 7.3.7. Denmark
      • 7.3.7.1. Denmark Obesity Treatment Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 7.3.8. Norway
      • 7.3.8.1. Norway Obesity Treatment Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 7.3.9. Sweden
      • 7.3.9.1. Sweden Obesity Treatment Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 7.4. Asia Pacific
    • 7.4.1. Asia Pacific Obesity Treatment Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 7.4.2. China
      • 7.4.2.1. China Obesity Treatment Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 7.4.3. Japan
      • 7.4.3.1. Japan Obesity Treatment Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 7.4.4. India
      • 7.4.4.1. India Obesity Treatment Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 7.4.5. South Korea
      • 7.4.5.1. South Korea Obesity Treatment Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 7.4.6. Australia
      • 7.4.6.1. Australia Obesity Treatment Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 7.4.7. Thailand
      • 7.4.7.1. Thailand Obesity Treatment Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 7.5. Latin America
    • 7.5.1. Latin America Obesity Treatment Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 7.5.2. Brazil
      • 7.5.2.1. Brazil Obesity Treatment Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 7.5.3. Argentina
      • 7.5.3.1. Argentina Obesity Treatment Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 7.6. Middle East and Africa
    • 7.6.1. Middle East and Africa Obesity Treatment Market Estimates and Forecasts, 2017 - 2030 (USD Million)
    • 7.6.2. Saudi Arabia
      • 7.6.2.1. Saudi Arabia Obesity Treatment Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 7.6.3. UAE
      • 7.6.3.1. UAE Obesity Treatment Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 7.6.4. Kuwait
      • 7.6.4.1. Kuwait Obesity Treatment Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 7.6.5. South Africa
      • 7.6.5.1. South Africa Obesity Treatment Market Estimates and Forecasts, 2018 - 2030 (USD Million)

Chapter 8. Competitive Landscape

  • 8.1. Recent Developments & Impact Analysis by Key Market Participants
  • 8.2. Company Categorization
  • 8.3. Company Market Share Analysis, 2024
  • 8.4. Company Heat Map Analysis, 2024
  • 8.5. Company Profiles
    • 8.5.1. Novo Nordisk A/S.
      • 8.5.1.1. Participant's Overview
      • 8.5.1.2. Financial Performance
      • 8.5.1.3. Product Benchmarking
      • 8.5.1.4. Recent Developments/ Strategic Initiatives
    • 8.5.2. GSK plc.
      • 8.5.2.1. Participant's Overview
      • 8.5.2.2. Financial Performance
      • 8.5.2.3. Product Benchmarking
      • 8.5.2.4. Recent Developments/ Strategic Initiatives
    • 8.5.3. VIVUS LLC
      • 8.5.3.1. Participant's Overview
      • 8.5.3.2. Financial Performance
      • 8.5.3.3. Product Benchmarking
      • 8.5.3.4. Recent Developments/ Strategic Initiatives
    • 8.5.4. Currax Pharmaceuticals
      • 8.5.4.1. Participant's Overview
      • 8.5.4.2. Financial Performance
      • 8.5.4.3. Product Benchmarking
      • 8.5.4.4. Recent Developments/ Strategic Initiatives
    • 8.5.5. Boehringer Ingelheim International GmbH
      • 8.5.5.1. Participant's Overview
      • 8.5.5.2. Financial Performance
      • 8.5.5.3. Product Benchmarking
      • 8.5.5.4. Recent Developments/ Strategic Initiatives
    • 8.5.6. Rhythm Pharmaceuticals, Inc.
      • 8.5.6.1. Participant's Overview
      • 8.5.6.2. Financial Performance
      • 8.5.6.3. Product Benchmarking
      • 8.5.6.4. Recent Developments/ Strategic Initiatives
    • 8.5.7. Gelesis
      • 8.5.7.1. Participant's Overview
      • 8.5.7.2. Financial Performance
      • 8.5.7.3. Product Benchmarking
      • 8.5.7.4. Recent Developments/ Strategic Initiatives
    • 8.5.8. Eli Lilly and Company.
      • 8.5.8.1. Participant's Overview
      • 8.5.8.2. Financial Performance
      • 8.5.8.3. Product Benchmarking
      • 8.5.8.4. Recent Developments/ Strategic Initiatives

List of Tables

  • Table 1 List of Secondary Sources
  • Table 2 List of Abbreviations
  • Table 3 Global Obesity Treatment Market, by Drug Class, 2018 - 2030 (USD Million)
  • Table 4 Global Obesity Treatment Market, by Route of Administration, 2018 - 2030 (USD Million)
  • Table 5 Global Obesity Treatment Market, by Distribution Channel, 2018 - 2030 (USD Million)
  • Table 6 North America Obesity Treatment Market, by Country, 2018 - 2030 (USD Million)
  • Table 7 North America Obesity Treatment Market, by Drug Class, 2018 - 2030 (USD Million)
  • Table 8 North America Obesity Treatment Market, by Route of Administration, 2018 - 2030 (USD Million)
  • Table 9 North America Obesity Treatment Market, by Distribution Channel, 2018 - 2030 (USD Million)
  • Table 10 U.S. Obesity Treatment Market, by Drug Class, 2018 - 2030 (USD Million)
  • Table 11 U.S. Obesity Treatment Market, by Route of Administration, 2018 - 2030 (USD Million)
  • Table 12 U.S. Obesity Treatment Market, by Distribution Channel, 2018 - 2030 (USD Million)
  • Table 13 Canada Obesity Treatment Market, by Drug Class, 2018 - 2030 (USD Million)
  • Table 14 Canada Obesity Treatment Market, by Route of Administration, 2018 - 2030 (USD Million)
  • Table 15 Canada Obesity Treatment Market, by Distribution Channel, 2018 - 2030 (USD Million)
  • Table 16 Mexico Obesity Treatment Market, by Drug Class, 2018 - 2030 (USD Million)
  • Table 17 Mexico Obesity Treatment Market, by Route of Administration, 2018 - 2030 (USD Million)
  • Table 18 Mexico Obesity Treatment Market, by Distribution Channel, 2018 - 2030 (USD Million)
  • Table 19 Europe Obesity Treatment Market, by Country, 2018 - 2030 (USD Million)
  • Table 20 Europe Obesity Treatment Market, by Drug Class, 2018 - 2030 (USD Million)
  • Table 21 Europe Obesity Treatment Market, by Route of Administration, 2018 - 2030 (USD Million)
  • Table 22 Europe Obesity Treatment Market, by Distribution Channel, 2018 - 2030 (USD Million)
  • Table 23 Germany Obesity Treatment Market, by Drug Class, 2018 - 2030 (USD Million)
  • Table 24 Germany Obesity Treatment Market, by Route of Administration, 2018 - 2030 (USD Million)
  • Table 25 Germany Obesity Treatment Market, by Distribution Channel, 2018 - 2030 (USD Million)
  • Table 26 U.K. Obesity Treatment Market, by Drug Class, 2018 - 2030 (USD Million)
  • Table 27 U.K. Obesity Treatment Market, by Route of Administration, 2018 - 2030 (USD Million)
  • Table 28 U.K. Obesity Treatment Market, by Distribution Channel, 2018 - 2030 (USD Million)
  • Table 29 France Obesity Treatment Market, by Drug Class, 2018 - 2030 (USD Million)
  • Table 30 France Obesity Treatment Market, by Route of Administration, 2018 - 2030 (USD Million)
  • Table 31 France Obesity Treatment Market, by Distribution Channel, 2018 - 2030 (USD Million)
  • Table 32 Italy Obesity Treatment Market, by Drug Class, 2018 - 2030 (USD Million)
  • Table 33 Italy Obesity Treatment Market, by Route of Administration, 2018 - 2030 (USD Million)
  • Table 34 Italy Obesity Treatment Market, by Distribution Channel, 2018 - 2030 (USD Million)
  • Table 35 Spain Obesity Treatment Market, by Drug Class, 2018 - 2030 (USD Million)
  • Table 36 Spain Obesity Treatment Market, by Route of Administration, 2018 - 2030 (USD Million)
  • Table 37 Spain Obesity Treatment Market, by Distribution Channel, 2018 - 2030 (USD Million)
  • Table 38 Denmark Obesity Treatment Market, by Drug Class, 2018 - 2030 (USD Million)
  • Table 39 Denmark Obesity Treatment Market, by Route of Administration, 2018 - 2030 (USD Million)
  • Table 40 Denmark Obesity Treatment Market, by Distribution Channel, 2018 - 2030 (USD Million)
  • Table 41 Sweden Obesity Treatment Market, by Drug Class, 2018 - 2030 (USD Million)
  • Table 42 Sweden Obesity Treatment Market, by Route of Administration, 2018 - 2030 (USD Million)
  • Table 43 Sweden Obesity Treatment Market, by Distribution Channel, 2018 - 2030 (USD Million)
  • Table 44 Norway Obesity Treatment Market, by Drug Class, 2018 - 2030 (USD Million)
  • Table 45 Norway Obesity Treatment Market, by Route of Administration, 2018 - 2030 (USD Million)
  • Table 46 Norway Obesity Treatment Market, by Distribution Channel, 2018 - 2030 (USD Million)
  • Table 47 Asia Pacific Obesity Treatment Market, by Country, 2018 - 2030 (USD Million)
  • Table 48 Asia Pacific Obesity Treatment Market, by Drug Class, 2018 - 2030 (USD Million)
  • Table 49 Asia Pacific Obesity Treatment Market, by Route of Administration, 2018 - 2030 (USD Million)
  • Table 50 Asia Pacific Obesity Treatment Market, by Distribution Channel, 2018 - 2030 (USD Million)
  • Table 51 China Obesity Treatment Market, by Drug Class, 2018 - 2030 (USD Million)
  • Table 52 China Obesity Treatment Market, by Route of Administration, 2018 - 2030 (USD Million)
  • Table 53 China Obesity Treatment Market, by Distribution Channel, 2018 - 2030 (USD Million)
  • Table 54 Japan Obesity Treatment Market, by Drug Class, 2018 - 2030 (USD Million)
  • Table 55 Japan Obesity Treatment Market, by Route of Administration, 2018 - 2030 (USD Million)
  • Table 56 Japan Obesity Treatment Market, by Distribution Channel, 2018 - 2030 (USD Million)
  • Table 57 India Obesity Treatment Market, by Drug Class, 2018 - 2030 (USD Million)
  • Table 58 India Obesity Treatment Market, by Route of Administration, 2018 - 2030 (USD Million)
  • Table 59 India Obesity Treatment Market, by Distribution Channel, 2018 - 2030 (USD Million)
  • Table 60 South Korea Obesity Treatment Market, by Drug Class, 2018 - 2030 (USD Million)
  • Table 61 South Korea Obesity Treatment Market, by Route of Administration, 2018 - 2030 (USD Million)
  • Table 62 South Korea Obesity Treatment Market, by Distribution Channel, 2018 - 2030 (USD Million)
  • Table 63 Australia Obesity Treatment Market, by Drug Class, 2018 - 2030 (USD Million)
  • Table 64 Australia Obesity Treatment Market, by Route of Administration, 2018 - 2030 (USD Million)
  • Table 65 Australia Obesity Treatment Market, by Distribution Channel, 2018 - 2030 (USD Million)
  • Table 66 Thailand Obesity Treatment Market, by Drug Class, 2018 - 2030 (USD Million)
  • Table 67 Thailand Obesity Treatment Market, by Route of Administration, 2018 - 2030 (USD Million)
  • Table 68 Thailand Obesity Treatment Market, by Distribution Channel, 2018 - 2030 (USD Million)
  • Table 69 Latin America Obesity Treatment Market, by Country, 2018 - 2030 (USD Million)
  • Table 70 Latin America Obesity Treatment Market, by Drug Class, 2018 - 2030 (USD Million)
  • Table 71 Latin America Obesity Treatment Market, by Route of Administration, 2018 - 2030 (USD Million)
  • Table 72 Latin America Obesity Treatment Market, by Distribution Channel, 2018 - 2030 (USD Million)
  • Table 73 Brazil Obesity Treatment Market, by Drug Class, 2018 - 2030 (USD Million)
  • Table 74 Brazil Obesity Treatment Market, by Route of Administration, 2018 - 2030 (USD Million)
  • Table 75 Brazil Obesity Treatment Market, by Distribution Channel, 2018 - 2030 (USD Million)
  • Table 76 Argentina Obesity Treatment Market, by Drug Class, 2018 - 2030 (USD Million)
  • Table 77 Argentina Obesity Treatment Market, by Route of Administration, 2018 - 2030 (USD Million)
  • Table 78 Argentina Obesity Treatment Market, by Distribution Channel, 2018 - 2030 (USD Million)
  • Table 79 Middle East & Africa Obesity Treatment Market, by Country, 2018 - 2030 (USD Million)
  • Table 80 Middle East & Africa Obesity Treatment Market, by Drug Class, 2018 - 2030 (USD Million)
  • Table 81 Middle East & Africa Obesity Treatment Market, by Route of Administration, 2018 - 2030 (USD Million)
  • Table 82 Middle East & Africa Obesity Treatment Market, by Distribution Channel, 2018 - 2030 (USD Million)
  • Table 83 South Africa Obesity Treatment Market, by Drug Class, 2018 - 2030 (USD Million)
  • Table 84 South Africa Obesity Treatment Market, by Route of Administration, 2018 - 2030 (USD Million)
  • Table 85 South Africa Obesity Treatment Market, by Distribution Channel, 2018 - 2030 (USD Million)
  • Table 86 Saudi Arabia Obesity Treatment Market, by Drug Class, 2018 - 2030 (USD Million)
  • Table 87 Saudi Arabia Obesity Treatment Market, by Route of Administration, 2018 - 2030 (USD Million)
  • Table 88 Saudi Arabia Obesity Treatment Market, by Distribution Channel, 2018 - 2030 (USD Million)
  • Table 89 UAE Obesity Treatment Market, by Drug Class, 2018 - 2030 (USD Million)
  • Table 90 UAE Obesity Treatment Market, by Route of Administration, 2018 - 2030 (USD Million)
  • Table 91 UAE Obesity Treatment Market, by Distribution Channel, 2018 - 2030 (USD Million)
  • Table 92 Kuwait Obesity Treatment Market, by Drug Class, 2018 - 2030 (USD Million)
  • Table 93 Kuwait Obesity Treatment Market, by Route of Administration, 2018 - 2030 (USD Million)
  • Table 94 Kuwait Obesity Treatment Market, by Distribution Channel, 2018 - 2030 (USD Million)

List of Figures

  • Fig. 1 Obesity treatment market segmentation
  • Fig. 2 Market research process
  • Fig. 3 Data triangulation techniques
  • Fig. 4 Primary research pattern
  • Fig. 5 Value chain based sizing & forecasting
  • Fig. 6 QFD modelling for market share assessment
  • Fig. 7 Market formulation & validation
  • Fig. 8 Market snapshot
  • Fig. 9 Drug class and route of administration segment snapshot
  • Fig. 10 Distribution channel Segment snapshot
  • Fig. 11 Competitive landscape snapshot
  • Fig. 12 Parent market outlook, 2024 (USD Billion)
  • Fig. 13 Bariatric surgery devices market outlook (USD Billion)
  • Fig. 14 Liposuction surgery devices market outlook (USD Billion
  • Fig. 15 Endoscopy procedures market outlook (USD Billion)
  • Fig. 16 Market trends & outlook
  • Fig. 17 Porter's five force analysis
  • Fig. 18 PESTEL analysis
  • Fig. 19 Obesity treatment market: Drug class outlook and key takeaways
  • Fig. 20 Obesity treatment market: Drug class movement analysis
  • Fig. 21 GLP-1 receptor agonists market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 22 Semaglutide (Wegovy) market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 23 Liraglutide (Saxenda) market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 24 Tirzepatide (Zepbound) market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 25 Lipase inhibitors market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 26 Appetite suppressants market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 27 Other drug class market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 28 Obesity treatment market: Route of administration outlook and key takeaways
  • Fig. 29 Obesity treatment market: Route of administration movement analysis
  • Fig. 30 Oral market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 31 Parenteral market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 32 Obesity treatment market: Distribution channel outlook and key takeaways
  • Fig. 33 Obesity treatment market: Distribution channel movement analysis
  • Fig. 34 Retail pharmacies market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 35 Hospital pharmacies market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 36 Others market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 37 Obesity treatment market revenue, by region, 2024 & 2030(USD Million)
  • Fig. 38 Regional marketplace: Key takeaways
  • Fig. 39 Obesity death share, 2021
  • Fig. 40 Death rate from obesity (deaths per 100000 people), 2021
  • Fig. 41 Share of obese or overweight children, 2022
  • Fig. 42 North America obesity treatment market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 43 Key country dynamics
  • Fig. 44 U.S. obesity treatment market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 45 Prevalence of obesity in adults aged 20 and older, by sex and age in the U.S. August 2021-Augutst 2023
  • Fig. 46 Prevalence of severe obesity in adults aged 20 and older, by sex and age in the U.S. August 2021-Auguts 2023
  • Fig. 47 Obesity prevalence across states (2023)
  • Fig. 48 Key country dynamics
  • Fig. 49 Canada obesity treatment market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 50 Key country dynamics
  • Fig. 51 Mexico obesity treatment market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 52 Europe obesity treatment market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 53 Key country dynamics
  • Fig. 54 UK obesity treatment market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 55 Prevalence of obesity and overweight UK 2022
  • Fig. 56 Key country dynamics
  • Fig. 57 Germany obesity treatment market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 58 Key country dynamics
  • Fig. 59 France obesity treatment market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 60 Key country dynamics
  • Fig. 61 Italy obesity treatment market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 62 Key country dynamics
  • Fig. 63 Spain obesity treatment market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 64 Key country dynamics
  • Fig. 65 Denmark obesity treatment market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 66 Key country dynamics
  • Fig. 67 Sweden obesity treatment market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 68 Key country dynamics
  • Fig. 69 Norway obesity treatment market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 70 Rest of Europe obesity treatment market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 71 Asia Pacific obesity treatment market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 72 Obesity prevalence in South East Asia (Millions)
  • Fig. 73 Key country dynamics
  • Fig. 74 Japan obesity treatment market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 75 Key country dynamics
  • Fig. 76 China obesity treatment market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 77 Key country dynamics
  • Fig. 78 India obesity treatment market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 79 Key country dynamics
  • Fig. 80 Australia obesity treatment market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 81 Key country dynamics
  • Fig. 82 Thailand obesity treatment market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 83 Key country dynamics
  • Fig. 84 South Korea obesity treatment market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 85 Rest of Asia Pacific obesity treatment market estimates and forecast, 2018 - 2030 (USD Million)
  • Fig. 86 Latin America obesity treatment market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 87 Key country dynamics
  • Fig. 88 Brazil obesity treatment market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 89 Key country dynamics
  • Fig. 90 Argentina obesity treatment market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 91 Rest of Latin America obesity treatment market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 92 MEA obesity treatment market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 93 Key country dynamics
  • Fig. 94 South Africa obesity treatment market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 95 Key country dynamics
  • Fig. 96 Saudi Arabia obesity treatment market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 97 Key country dynamics
  • Fig. 98 UAE obesity treatment market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 99 Key country dynamics
  • Fig. 100 Kuwait obesity treatment market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 101 Rest of MEA obesity treatment market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 102 Company/competition categorization
  • Fig. 103 Company market share analysis, 2024
  • Fig. 104 Company market position analysis, 2024
  • Fig. 105 Strategy mapping